Sole control: The French Competition Authority clears the takeover of a company specialised in the distribution of pharmaceutical products by a group in the same sector subject to behavioural commitments (McKesson Europe / Phoenix)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. In the last few days, the French Competition Authority has posted 31 new merger clearance decisions online, including 29 simplified decisions. Among these decisions is decision n° 22-DCC-186 of September 30, 2022 in which the French Competition Authority authorized, after partial referral by the Commission of the examination of the effects of the transaction in France, the acquisition of sole control of McKesson Europe by the Phoenix group, both of which are essentially active in the pharmaceutical distribution sector and, more specifically, in pharmaceutical distribution as wholesaler-distributors. The Phoenix Group operates as an integrated healthcare

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Sole control: The French Competition Authority clears the takeover of a company specialised in the distribution of pharmaceutical products by a group in the same sector subject to behavioural commitments (McKesson Europe / Phoenix), 30 September 2022, Concurrences N° 4-2022, Art. N° 109726, www.concurrences.com

Visites 144

All reviews